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ABSTRACT 
Woolf-May K, Scott A, Kearney E, Jones DW. The Effects of 24 
Weeks of Moderate Intensity Walking upon Metabolic Syndrome Risk 
Factors in Previously Sedentary/Low Active Men. JEPonline 
2011;14(4):145-156. This study determined the effects of 24 weeks of 
walking on risk factors and insulin sensitivity associated with 
metabolic syndrome (MetS) in men. Forty-eight (28.4±3.2 BMI) 
sedentary/low-active men were randomly selected into controls (n=19, 
52.4±8.0) or walkers (n=29, 54.9±8.0 yrs). Over a 24-week period, 
156.4±26.5 min·walking·wk-1 was performed in 7.2±2.9 sessions·wk-1 
for a mean of 25.1±10.3 min·session-1 at an estimated relative VO2 
max of 50.6±9.1%. GLM statistical analysis using the baseline values 
as a covariate was employed. Bonferroni correction set significance at 
P<0.006.  Significant post-intervention changes were observed in 
waist circumference (WC) (walkers -2.0±2.7 vs. controls +1.3±3.1 cm, 
P<0.0001); waist/hip (W/H) ratio (-0.02 ±0.03 vs. +0.01±0.03, 
P<0.0001), serum insulin (-1.7±1.5 vs. +2.0±6.0, P<0.006 µU·ml-1), 
and insulin sensitivity index (ISI) (+2.0±6.0 vs. -0.4±0.7, P<0.002 
M·mU-1·L-1, respectively). The post-intervention changes: insulin 
correlated with WC (R=0.441; P<0.002); ISI negatively with WC (R=-
0.433; P<0.003), indicating the changes in body composition to have 
affected insulin metabolism and insulin sensitivity. The men who 
walked at an easily attainable intensity for most mobile adults of ~51% 
of relative VO2 max showed reduced WC and enhanced insulin 
sensitivity, thus reducing their risk of MetS and type II diabetes. 
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INTRODUCTION  
 
Metabolic syndrome (MetS) is characterized by insulin resistance in the presence of obesity and high 
levels of abdominal fat, blood glucose, insulin, cholesterol and triglycerides as well as low levels of 
high-density lipoprotein cholesterol and high blood pressure. For men, MetS is defined when an 
individual possesses three or more of the following risk factors: waist circumference (WC) >40 inches 
(102 cm); fasting blood triglyceride (TG) levels ≥150 mg·dL-1 (1.69 mmol·L-1) and high-density 
lipoprotein cholesterol (HDL-C) ≤40 mg·dL-1 (1.04 mmol·L-1); blood pressure (BP) ≥130 systolic and 
diastolic 85 mmHg and fasting blood glucose ≥110 mg·dL-1 (6.1 mmol·L-1) (1).  Individuals with MetS 
are three times as likely to suffer a myocardial infarction or stroke and twice as likely to die from 
either. They are also at a fivefold greater risk of developing type II diabetes (37).   
 
Metabolic syndrome is extremely common in western societies (10) and likely to increase with the 
observed rising rates of obesity (32).  Causes of MetS have been recognized to involve factors such 
as ageing, a pro-inflammatory state, hormonal changes, and physical inactivity; all of which may vary 
depending upon heredity factors and ethnic origin (17,34). Yet, despite high levels of moderate 
intensity physical activity and aerobic fitness being inversely associated with MetS (18), there is still 
little empirical research to determine the direct effect of physical activity or walking intervention on 
reducing MetS. This is especially the case given the current criterion factors in a single study 
(17,21,22,27). Given that walking is an easily accessible mode of exercise for the majority of the 
population, the purpose of this investigation was to determine the effects of 24 weeks of walking (5, 
31) on risk factors and insulin sensitivity associated with metabolic syndrome (MetS) (37) in men. 
 
METHODS 
Subjects and Recruitment  
Volunteers were recruited over 13 months via posters, university website, and local media.  They 
were provided with an information sheet and required to sign informed consent.  Their suitability was 
determined through medical and physical activity/lifestyle screening questionnaires, and their general 
practitioner’s approval. Inclusion criteria allowed men to participate if they engaged in <30 min of 
accumulated physical activity 5 days of the week, were non-diabetic, non-smoking, free of known 
cardiovascular disease, with a waist/hip ratio ≥0.87, between 38 and 75 yrs of age, and understood 
the purpose of the study.  Eighty-seven men volunteered, after screening 49 remained.  They were 
randomly selected (using computer generated sequences) into either group controls or walkers.  The 
results presented are from the 48 participants who completed the study, which was approved by the 
local NHS Research Ethics and Canterbury Christ Church University (CCCU) Faculty Research 
Ethics Committees.   
 
Variables of Interest  
Variables of interest were collected pre- and post-intervention in the Sport Science Laboratory at 
(SSL) CCCU. These included body mass (BM), waist circumference (WC), hip circumference (HC), 
waist/hip (W/H) ratio, and samples of fasted venous blood.  The venous blood was used to determine 
insulin and insulin resistance (insulin sensitivity index, ISI), fibrinogen, total cholesterol (TC), 
triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol 
(LDL-C). Measures of systolic (SBP), diastolic blood pressure (DBP), and graded treadmill-walking 
test to predict maximal aerobic capacity (VO2) were also taken as well as data from walking diaries to 
determine walking intensity, duration, and compliance.   
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Aerobic Fitness and Walking Intensity 
All participants were familiarized with the treadmill (Mercury Med., HP Cosmos, Nussdorf-Traunstein, 
Germany) and protocol (Naughton-Balke) on a separate occasion prior to the main tests.  Participants 
were requested not to eat or drink any liquid with caffeine or carbohydrate (water was permitted) at 
least 2 hrs before the treadmill test or to consume alcohol or perform rigorous physical activity within 
the previous 24-hr period. After seated for at least 5 min, pre-test blood pressure was measured from 
the right arm using an aneroid sphygmomanometer (Accoson Limpet, A.C. Cossor & Son Ltd, 
London, UK). Height and BM were determined using the stadiometer and clinical scales (Seca 
052466, Germany), respectively, while participants wore similar sporting clothing on both occasions.  
Throughout the test each subject wore a facemask (Large 7400 Vmask series oro-nasal with custom 
adapter for Jaeger Triple-V turbine pneumotach). Expired air was measured breath-by-breath and 
analyzed every 5 secs (Oxycon Pro, Jäeger, Würzburg, Germany).  Oxygen uptake (VO2 max in 
mL·kg-1·min-1) was estimated by extrapolating HR versus VO2 to the age predicted maximum HR of 
220-age. Ratings of perceived exertion (RPE) were taken at the end of each 2-min stage (3).   Gross 
energy expenditure at particular walking speeds was calculated from absolute VO2 (e.g., 5 kcal per 
liter of VO2).   
 
Anthropometric Measures  
While each subject stood in an anatomical neutral position, waist circumference was measured at the 
umbilicus level and HC at largest point above the gluteal fold to the nearest 1 mm using a self-
tightening circumference tape measure (Seca, Hamburg, Germany). The mean of three measures 
was taken, and recorded (intra-subject CV 0.5% and between 9.9%); W/H was subsequently derived.   
 
Blood Samples  
Each participant’s blood was taken following an overnight fast (~14 hrs), collected into vacutainers 
(BD Systems, Oxford, UK) and dispensed into one tube to form serum (containing 0.105 mm sodium 
citrate at a ratio of 9 parts blood to 1 part anticoagulant), and two others to form plasma (containing 
fluoride/oxalate). The samples were then centrifuged at room temperature (Eppendorf 5804, 
Hamburg, Germany) and stored at -70 °C (Revco Ultra, Asheville, NC, USA) for later analysis. The 
sera were then analysed for TG, TC and HDL-C (all Horiba ABX Diagnostics, Cambridge) using 
enzymatic colorimetric analyses. From these data LDL-C was calculated (11). The plasma was 
analyzed for glucose (Horiba ABX, Cambridge). The plasma collected in the sodium citrate tubes 
were analyzed for fibrinogen (4) at Kent and Canterbury Hospital. Insulin was analyzed from serum 
using chemiluminescence (Bayer Advia Centaur, Bayer Healthcare, Diagnostics Division, Tarrytown, 
NY), and ISI (26) was determined at QEQM Hospital, Margate. The samples were analyzed within the 
same assay series to reduce variability within the biochemical analytical procedure, and were 
corrected for changes in plasma volume (6). The intra assay coefficient of variations, using low 
concentration quality control (QC) sera were: TC, 3.82%; HDL-C, 6.90%; TG, 8.04%; glucose, 2.24%; 
insulin, 1.75%; and fibrinogen, 4.18%.  
 
Intervention  
All participants were requested not to significantly change their lifestyle or diet over the 24-week 
period (i.e., other than the walking for the ‘active’ group). Walkers were required to walk for 30 min in 
bouts of no <10 min per session, on at least 5 days of the week, at a ‘brisk’ pace (defined as an RPE 
and HR equivalent to around 65% of each individual’s HR max).  Participants could choose how, 
where, and when they walked. Though not supervised, walkers were regularly contacted and 
provided with a diary in which to record the date, duration (min), and intensity (RPE and HR from the 
wrist) of each session.  While acknowledging the limitations of this approach, it was chosen to 
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achieve a greater level of ecological validity.  Using these data and the data from the treadmill test, it 
was possible to gain an indication of walking intensity for each walker.    
 
Statistical Analysis  
Power analysis was performed to determine that an active group of n=29 would be sufficient to show 
post-intervention changes in the variables of interest and would achieve 90% power at an alpha of 
0.05. Minitab statistical package (version 15) was employed with variability of data within a 
distribution given as one standard deviation (mean±SD).  Bonferroni correction factor was applied, 
moving the alpha level of significance to 0.006 for between group differences.  Data that lacked 
normal distribution underwent natural logarithmic transformation.  Baseline data between groups were 
compared using a one-way analysis of variance (ANOVA). Post-intervention between group changes 
were compared employing the Generalised Linear Model (GLM) using baseline data as a covariate.  
Pearson’s Product Moment correlation and multiple regression analyses were used to explore 
relationships between factors (with an alpha 0.05 level of statistical significance). Statistically 
significant relationships showing a correlation of less than R=0.400 are not reported.   
 
RESULTS 
Subject Characteristics  
At baseline the two groups did not differ significantly for: (a) age (controls, n=19, 52.4±8.0, range 40 
to 69 vs. walkers, n=29, 54.9±8.0, range 38 to 73 yrs, F=1.17, P=0.285); (b) height (1.77±0.05, range 
1.66 to 1.89 vs.1.79±0.06, range 1.69 to 1.92 m, F=1.60, P=0.212); (c) BMI (n=19, 29.3±3.4, range 
23.1 to 34.9 vs. n=29, 27.8±3.1, range 22.0-33.5, F=2.49, P=0.122, respectively); (d) baseline 
physical activity levels (i.e., physical activity at >4 METs, controls 0.63±0.68 vs. walkers 0.84±0.61 
hrs·wk-1, F=1.16, P=0.284; indicating their pre-intervention levels of physical activity to be sufficiently 
low); and (e) BM or any of the other measured variables (refer to Tables 1 and 2). The mean group 
values were within the normal ranges for blood lipids, fibrinogen, glucose, insulin and ISI, and within 
the ‘good’ classification for aerobic capacity. Blood pressure readings were at the upper end for 
normal values, as were WC and subsequent W/H ratio values (Tables 1 and 2). Thus, the participants 
were considered pre-obese with borderline MetS.     
 
Metabolic Syndrome   
At baseline controls and walkers possessed a total of n=42 and n=57 MetS risk factors respectively, 
with n=8 (42%) and n=9 (31%) that would be classified as possessing MetS (1).   There was little 
change post-intervention with a total of n=44 and n=53 risk factors, and those classified with MetS 
being n=9 (47%) and n=8 (28%), respectively.  
 
Pre-Intervention  
Combined data from all participants showed that at baseline serum insulin  levels correlated with BM  
(R=0.586; R2=0.32: P≤0.0001), WC (R=0.518; R2=0.27: P≤0.0001) and HC (R=0.498; R2=0.25: 
P≤0.0001); and ISI negatively with BM  (R= -0.470; R2=0.22: P≤0.001), WC (R= -0.463; R2=0.22: 
P≤0.001) and HC (R= -0.410; R2=0.17: P≤0.001).  
 
Post-Intervention  
Insulin correlated with BM (R=0.557; R2=0.31: P≤0.0001), WC (R=0.519; R2=0.27: P≤0.0001), HC 
(R=0.486; R2=0.24: P≤0.001) and W/H ratio (R=0.403; R2=0.16: P≤0.005); and ISI negatively with BM  
(R= -0.432; R2=0.19: P≤<0.003) and WC (R=-0.406; R2=0.17: P≤0.005). Estimated VO2 max 
negatively correlated with SBP (R= -0.424; R2=0.18: P≤0.003).   
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Table 1.  Pre- and post-intervention values for anthropometric measure, VO2 max, and blood 
pressure; mean±SD (range). 
 Controls       
(n=19) 
  Walkers 
(n=29) 
   
Variable  Pre      Post Mean 
difference 
 Pre   Post Mean 
difference 
Between 
group P (F 
value) 
BM (kg) 91.7±10.6 
 70.4-106.5 
92.0±10.6 
71.0-107.8 
+3.5±3.1 
 
89.1±9.1 
69.0-103.0 
88.4 ±9.4 
67.7-103.7 
-0.7±1.6 
 
0.148 (2.16) 
  
 
WC (cm) 102.5±9.5 
83.0-119.2 
103.8±9.6 
84.5-118.0 
+1.3±3.1  
 
101.2±8.0 
82.2-113.0 
99.2±8.4  
80.0-111.5 
-2.0±2.7* 0.0001 (15.27) 
 
 
HC (cm) 105.4±5.4 
95.0-112.5 
104.8±5.4 
95.5-115.5 
-0.6±2.7  
 
104.4±5.0 
93.2-114.5 
103.8±4.7 
92.5-112.5 
-0.6±2.1 0.872 (0.03) 
 
 
W/H ratio 0.97±0.06 
0.87-1.07 
0.99±0.07 
0.88-1.11 
+0.02±0.3 
 
0.95±0.05 
0.87-1.05 
0.95±0.05  
0.86-1.04 
-0.02±0.03* 0.000 (19.82) 
 
 
#VO2 max   
(mL·kg-1·min-1) 
35.6±7.5 
22.4-51.9 
35.9±6.2 
24.8-50.7 
+0.3±2.7 37.3±6.2 
26.8-59.5 
39.5±5.6 
29.7-52.0 
+2.2±3.5 0.011 (7.09) 
 
 
 
SBP (mmHg)  
 
132.3±15.4 
105.0-163.3 
 
129.2±151 
110.0-166.7 
 
-3.1±9.3 
 
129.2 ±14.4 
103.3-150.0 
 
122.7±12.6 
96.7-145.0 
 
-6.5±10.2 
 
0.119 (2.53) 
 
 
DBP (mmHg) 87.7±8.2 
75.0-101.7 
87.2±10.1 
75.0-110.0 
-0.6±8.2 84.3±9.5 
70.0-100.0 
82.6±9.2 
70.0-108.3 
-1.7±6.1 0.322 (1.00) 
*Statistically significantly different from controls as determined by GLM using baseline values as a covariate.  
Bonferroni adjustment factor applied shifting statistical significance to the alpha level to 0.006. #Estimated VO2 
max 
 
Post-Intervention Changes 
Statistical significant differences were observed in the amount of post-intervention change in WC, 
W/H ratio (Table 1), serum insulin and ISI values (Table 2).  The amount of change in insulin also 
significantly correlated with the amount of change in BM (R=0.412; R2=0.17: P≤0.004) and WC 
(R=0.441; R2=0.19: P≤0.002); and negatively with the amount of change in ISI with WC (R=-0.433; 
R2=0.19: P≤0.003). Furthermore, baseline measures significantly affected post-intervention degree of 
change for insulin (P=0.0001), fibrinogen (P≤0.0001), HDL-C (P≤0.0001), glucose (P≤0.0001), SBP 
(P=0.002) and estimated VO2 max (P≤0.0001).  Additionally, the number of walking sessions.wk-1 
(Table 3) correlated with degree of change in WC (R=0.494; R2=0.24: P≤0.006). There were no other 
significant changes or meaningful correlations. 
 
 
DISCUSSION  
Walking Intervention  
It was important that the walking intervention was as ecologically valid as possible. As such, the 
participants were guided to walk at a ‘brisk’ intensity of about 65% of their estimated HR max.  The 
mean weekly volume of walking performed over the 24 weeks was (156.4±26.5 min·wk-1) within the 
range recommended by the government (5,31).  The walkers recorded a mean walking intensity at an 
RPE of 11.9±1.4, which related to somewhere between ‘fairly light’ and ‘somewhat hard’ on the Borg 
scale (3).  They also walked at 65.2±6.9% of their estimated HR max, and at 50.6±9.1% of their 
estimated VO2 max, which is at the upper end of ‘light’ and within the lower end of the ‘moderate’ 
intensity exercise.   
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Table 2.  Pre- and post-intervention measures for blood lipids, insulin resistance and 
prothrombotic state; mean±SD (range).   
 Controls 
(n=19) 
  Walkers    
(n=29) 
   
Variable Pre  Post Mean 
difference 
Pre  Post Mean 
difference 
Between group P 
(F value) 
TC (mmol·L-1)  
C = 18; W = 28 
5.4±1.2 
2.0-7.1 
5.4±1.0 
3.7-7.8 
-0.5±0.9 5.3±1.0 
3.1-6.8 
5.1±1.0 
3.2-7.4 
 
-0.2±0.7 0.03 (0.16) 
 
TG (mmol·L-1)  
W = 28 
1.3± 0.4 
0.6-2.2 
1.6±0.8 
0.6-4.0 
+1.3±0.8 1.3±1.3 
0.7-2.3 
1.3±1.3 
0.43-2.4 
 
-0.03±0.04 0.054 (3.91) 
 
HDL-C (mmol·L-1)  
 
1.2±0.6 
0.4-3.1 
1.2±0.4 
0.7-2.4 
-0.01±0.7 1.2±0.4 
0.43-2.13 
1.3±0.6 
0.52-2.87 
 
-0.1±0.6 0.54 (0.37) 
 
LDL-C (mmol·L-1)  
W = 28 
3.6±1.0 
1.3-5.5 
3.5±0.9 
0.8-4.8 
-0.1±0.8 3.5±0.9 
1.6-4.9 
3.2±1.1 
0.6-5.4 
 
-0.2±0.5 0.574 (0.43) 
 
Glucose (mmol·L-1) 
C = 18; W = 28 
5.7±0.9 
4.2-8.5 
5.8±0.7 
4.0-7.9 
+0.1±0.6 5.4±0.7 
3.5-7.2 
5.7±0.8 
4.4-8.9 
 
-0.3±0.6 0.814 (0.06) 
 
Insulin (µU·mL-1)  
W = 27 
12.7±12.3 
6.0-26.8 
14.7±5.7 
5.6-23.6 
+2.0±6.0 11.7±10.6 
3.3-32.3 
10.0±9.7 
3.1-24.6  
 
-1.7±1.5* 
 
0.006 (8.40) 
 
ISI (M·mU-1·L-1) 
W = 27 
10.0±0.7 
8.7-11.4 
9.6±1.0 
8.2-12.0 
-0.4±0.7 10.2±0.6 
9.0-11.3 
10.4±0.8 
9.3-12.7 
 
+0.2±0.3* 
 
0.002 (10.82) 
 
Fibrinogen (g·L-1)  
C = 17; W = 25 
2.9±2.8 
1.5-5.7 
3.0±3.0 
2.0-4.4 
+0.1±0.7 3.1±3.1 
2.4-4.1 
2.9±2.9 
1.9-4.0 
-0.18±0.2 0.206 (1.65) 
 
 
C = controls, W = walkers. * Significantly different amount of change compared to C as determined by GLM, using 
baseline values as a covariate.  Bonferroni adjustment factor applied shifting statistical significance to the alpha level to 
0.006. Due to technical difficulties some of the subject numbers may differ in some of the variables.  Therefore, where 
group sizes differ, group numbers are provided.  
 
 
Interestingly the participants of this study did however walk at a lower intensity (~51% VO2 max) than 
middle-aged men and women of other walking intervention studies (range 65% to 67% VO2 max) 
(29,40,41).  Furthermore, the intensity of our walkers was generally lower than a group of older 
women (n=9, aged 75 to 83 yrs) and slightly greater than a group of younger women (n=9, age 20-23 
years) who, when asked to walk briskly, walked at ~60% and ~72% of HR max, respectively (9). 
Adherence to the regimen was relatively high ranging from around 75% to 144% (113 min to 216 min) 
of the walking duration prescribed.   
 
It is of interest that the number of walking sessions per week correlated with change in WC (R=0.494, 
P=0.006) with no significant relationship being seen from the ‘total minutes walked’ or ‘mean time of 
each walking session’ within the whole program.  Therefore, this suggests that breaking the walking 
sessions into shorter bouts might have some favourable effect.  But, it is important to keep in mind 
that there were no other strong significant correlations to suggest shorter sessions produced more 
favourable changes in any of the other measured variables.  This latter point seems to agree with 
Hardman (14), who suggested that neither single nor multiple bouts of exercise of similar volume 
produced more favourable changes.   
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Table 3. Walking diary and derivative data; mean±SD (range). 
             Variable   Walkers (n=29) 
Weeks walked 23.7±0.7 (21-24) 
Total min walked 3699±640 (2710-5167) 
Mean min walked·wk-1  156.4±26.5 (112.9-220.6) 
Percentage of prescribed walking achieved  102.8±17.8 (75.3-143.5) 
RPE 11.9±1.4 (9-16) 
Palpated HR (beats·min-1) 108.5±18.5 (75.1-176.3) 
Walking intensity % estimated HR max 65.2±6.9 (50.7-78.4) 
Walking intensity % estimated VO2 max 50.6±9.1 (31.4-65.8) 
Estimated walking gross energy expenditure kcal·wk-1  1314.5±395.8 (511.4-2284.5) 
Estimated walking gross energy expenditure MJ·wk-1 5.6 ±1.7 (2.2-9.7) 
Sessions·wk-1 7.2±2.9 (4.2-15.0) 
Session duration (min) 25.1±10.3 (10.1-49.7) 
 
 
Metabolic Syndrome Related Risk Factors  
The walking intervention did not appear to have much impact upon the majority of the risk factors 
associated with MetS. Perhaps, it is important to remember that the walking intensity was relatively 
low (50.6±9.1%) compared to other walking intervention studies. Nonetheless, the walking group did 
significantly reduce their WC, which was accompanied by a reduction in serum insulin and associated 
increase in ISI. The findings imply that for the ‘at risk’ men, an additional 1.4 hrs·wk-1 of moderate 
intensity regular walking, above their baseline physical activity levels, decreased their risk of 
developing MetS and type II diabetes. In contrast however, the control group actually increased their 
WC over the intervention period, and showed a reduction in insulin sensitivity (see Table 2). Even 
though all participants were requested not to change their diet or other physical activity over the 
intervention, there is always a possibility when dealing with human subjects that this did occur.  This 
is difficult to fully control, and is continually a potential limitation of any study of this type.   
 
Notwithstanding, it was apparent that the observed changes in body composition were linked to the 
changes in insulin sensitivity.  Insulin levels and insulin sensitivity have been shown to change with 
alterations in fat mass (FM) (24), fat free mass (FFM) (13,30), the ratio of FM/FFM (23), and 
adaptations in skeletal muscle due to exercise training (16). The link between blood insulin and FM is 
seen most notably in obese individuals who commonly suffer from hyperinsulinaemia (24). The 
participants of this study were generally pre-insulin levels and ISI were within the normal range (ISI of 
≤ 6.3 M·mU-1·L-1 defined as insulin resistance), and the established relationships between WC, ISI 
and serum insulin levels were apparent.  Given that both groups showed no significant change in BM 
over the intervention, the findings would suggest an increase in FFM for the walkers and an increase 
in FM for the controls.  Insulin sensitivity has been found to increase when FFM is enhanced (30) and 
becomes reduced when there is a loss (13).  This would corroborate with the increase in insulin 
sensitivity in the walkers and the reduction in this factor for the controls.  
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Similar to our study, other researchers have also found reductions in fasting insulin after exercise 
intervention (7,12,15), which is often associated with adaptations in the trained muscle that results in 
enhances insulin sensitivity (16,33).  Hickey et al. (15) found reductions in plasma insulin levels in a 
group of 5 morbidly obese women after 7 days of cycle ergometry and treadmill walking at 65% VO2 
peak for 60 min.d-1). Their finding was reported as being unrelated to changes in body composition or 
glucose tolerance.  Likewise, Donnelly et al. (7) observed comparable reductions in serum insulin to 
the findings in the present study.  Their subjects consisted of 22 previously sedentary moderately 
obese women who exercised for 18 months via walking at 60 to 75% VO2 max with no significant 
changes in either blood glucose, FM or FFM.  This suggests that muscle adaptations to be the cause 
of the changes in insulin.  The data from the present study would however suggest that the increase 
in insulin levels and reduced ISI for the controls was likely due to the increase in their WC while the 
enhanced ISI, reduced insulin levels and WC seen in the walkers to be a probable combination of 
skeletal adaptations from the walking intervention and associated changes in WC, and subsequent 
ratio of FM/FFM. Given the significance of the relationships between insulin resistance in the 
presence of abdominal obesity to MetS, and the increased insulin resistance with an enhanced risk of 
myocardial infarction (38), the outcomes of this study are therefore of interest.   
 
Blood Pressure, Blood Lipids, and Fibrinogen   
It is clear that other than the changes stated above the exercise intervention did not have a 
statistically significant effect on the other measures of MetS. Also, while it is popular to argue from a 
clinical rather than statistical perspective (i.e., despite the lack of statistical significance the mean 
change in SBP and DBP for the walkers is important), the fact remains that the intervention did not 
produce a significant difference in blood pressure.  Therefore, it is scientifically incorrect to assume 
that the walkers would be in position to change their blood pressure classification.  Blood lipids also 
showed no statistically significant change, despite other researchers having observed changes in 
blood lipids from similar numbers of older aged subjects after exercise intervention of similar intensity 
(28,36). The findings of this study also showed mean 9% reduction in LDL-C for the walkers 
compared to 3% in the controls.  However, once again, while a 10% reduction in LDL-C has been 
shown to reduce cardiovascular death by around 10% and cardiovascular events by 25% (25), the 
statistical fact is that there were no differences in blood lipids between the groups after the 
intervention. 
It is also known that for an increase in HDL-C to occur the gross weekly energy expenditure through 
physical activity should be in the range of 1200 to 2200 kcal.wk-1 (~4.0-9.2 MJ) (8). Considering that 
the subjects in the walking group engaged in an estimated weekly gross energy expenditure within 
this range (Table 3), the lack of significant change might be due to the fact that generally their pre-
intervention blood lipid profiles were reasonably good.  This thinking is in agreement with reports by 
other researchers, who have argued that pre-intervention blood lipid profiles limit their potential for 
change (36,40). Furthermore, the subjects walked at around 51% VO2 max, which was considerably 
lower than 75% VO2 max, which has been shown to induce changes in blood lipid profile (42). It 
would also appear that in order for favourable changes in blood lipids to occur, when baseline values 
are relatively good, previously low sedentary/low active men may require exercising at a subjective 
intensity above that of a “brisk” intensity.  The lack of statistical change in fibrinogen is more difficult 
to determine, since research findings in this area have proven to be varied and equivocal 
(2,19,42,43). However as with the blood lipids our data showed that baseline levels appear to 
influence the degree and potential for change after the walking intervention.  
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CONCLUSIONS 
 
Given the importance of insulin resistance in the presence of abdominal obesity in relation to MetS 
and type II diabetes, the findings of this study demonstrate that for previously sedentary/low active 
men who engage in 30 min of walking throughout the day on at least 5 days of the week at an easily 
attainable intensity for most adults (~51% VO2 max), they can reduce their risk of MetS and type II 
diabetes. 
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